Deep Track Capital, LP 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 08:36 am Sale |
2023-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Deep Track Capital, LP | 0 0.000% |
-1,816,531 (Position Closed) |
Filing |
| 2023-02-14 08:27 am Unchanged |
2022-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Deep Track Capital, LP | 1,816,531 6.610% |
0 (Unchanged) |
Filing |
| 2022-12-22 4:02 pm Purchase |
2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS |
Deep Track Capital, LP | 1,816,531 7.320% |
1,816,531 (New Position) |
Filing |